BSE: 531173 | NSE: | Pharmaceuticals & Drugs | Small Cap
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | TTM | |||
| ROCE % ⓘ | 2.7% | 5.4% | 5.7% | -7.9% | -6.1% | -4.4% | 2% | 4% | -6.9% | -21.9% | - | ||
| Value Creation Index ⓘ | -0.8 | -0.6 | -0.6 | -1.6 | -1.4 | -1.3 | -0.9 | -0.7 | -1.5 | NA | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 10.6 | 16.2 | 18.4 | 11.4 | 3.7 | 12.5 | 66.5 | 93.1 | 76.9 | 68.5 | 76 | ||
| YoY Gr. Rt. % | - | 52.4% | 13.8% | -38.3% | -67.9% | 243.3% | 430.8% | 40% | -17.4% | -11% | - | ||
| Adj EPS ⓘ | 0.2 | 0.6 | 0.4 | -2.4 | -1.4 | -0.9 | 0.3 | 0.6 | -1 | -2.5 | -3.2 | ||
| YoY Gr. Rt. % | - | 185.7% | -38.3% | -756.8% | NA | NA | NA | 103.5% | -266.1% | NA | - | ||
| BVPS (₹) ⓘ | 7.7 | 8.4 | 8.7 | 6.3 | 4.9 | 4.6 | 4.9 | 6.2 | 5.2 | 3.3 | 2.4 | ||
| Adj Net Profit ⓘ | 0.3 | 1 | 0.6 | -3.9 | -2.2 | -1.4 | 0.5 | 1.1 | -1.8 | -5.4 | -7 | ||
| Cash Flow from Ops. ⓘ | -0.4 | 4 | 3.9 | 1.3 | 0.5 | 6.4 | 0 | -1.7 | 3.5 | 3.7 | - | ||
| Debt/CF from Ops. ⓘ | -35.2 | 7.5 | 7.9 | 21.2 | 55.9 | 3.2 | 2267.9 | -8.6 | 4.8 | 4.1 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | 23% | 79.8% | 1% | -11% | ||||||||
| Adj EPS ⓘ | -231.6% | NA | -304.8% | NA | ||||||||
| BVPS ⓘ | -9.2 | -7.8 | -12.9 | -37.9 | ||||||||
| Share Price | 0.4% | 8.9% | 14.5% | 120.1% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | TTM | ||
| Return on Equity % ⓘ | 2.9 | 6.9 | 4.1 | -29.9 | -22.7 | -17.6 | 5.7 | 10.5 | -16.7 | -62.7 | -112.6 | |
| Op. Profit Mgn % ⓘ | 14.4 | 23.6 | 22 | -22.7 | -24.2 | 0.5 | 4.5 | 4.4 | -0.1 | -7.1 | -9 | |
| Net Profit Mgn % ⓘ | 3.1 | 5.9 | 3.2 | -34.1 | -61.4 | -11.3 | 0.7 | 1.2 | -2.4 | -7.8 | -9.8 | |
| Debt to Equity ⓘ | 1.2 | 2.1 | 2.1 | 2.5 | 3 | 2.8 | 2.4 | 1.3 | 1.7 | 2.2 | 2 | |
| Working Cap Days ⓘ | 249 | 246 | 284 | 500 | 1,407 | 334 | 90 | 99 | 136 | 181 | 285 | |
| Cash Conv. Cycle ⓘ | 99 | 128 | 153 | 240 | 694 | 12 | -29 | -25 | -27 | -1 | 101 | |
Sales growth is good in last 4 quarters at 11.79%
Return on Equity is Poor
Sales growth has been subdued in last 3 years 0.98%
Debt to equity has increased versus last 3 years average to 2.17
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | -3.2 | - |
| TTM Sales (₹ Cr.) | 75.6 | - |
| BVPS (₹.) ⓘ | 2.4 | - |
| Reserves (₹ Cr.) ⓘ | -18 | - |
| P/BV ⓘ | 6.48 | - |
| PE ⓘ | 0.00 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 6.56 / 18.35 |
| All Time Low / High (₹) | 2.50 / 80.50 |
| Market Cap (₹ Cr.) | 36 |
| Equity (₹ Cr.) | 23.3 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 40.9 |
| Pledged * | 44.71 | 16.18 | 20.28 | 20.20 | 19.47 | 19.47 | 19.47 | 19.47 | 10.51 | 10.51 |
Syschem India was incorporated on December 31, 1993 as Anil Pesticides and obtained certificate of commencement of business on February 1, 1994. The company is promoted by Anil Nibber, Atul Nibber and Ajay Kumar Singla.
Anil Pesticides has taken effective steps for putting up a project for manufacturing pesticides' namely Monocrotophos (MCP) and Dichlorvos (DDVP). The project is being put up with equity participation of Haryana State Industrial Development Corporation, an undertaking of the Government of Haryana.
The registered office of the company is located at Tehsil Kalka, District Panchkula, Punchkula, Haryana 134109.
My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
